Biomanufacturing Consortium (BioMAN)

The Biomanufacturing consortium (BioMAN) seeks to develop new knowledge, science, technologies, and strategies that advance the manufacture and global delivery of high quality biopharmaceuticals. As a neutral third party, MIT provides a pre-competitive environment where stake-holders can work together to develop improvements in biomanufacturing.

BioMAN connects industry, academia, and government to identify challenges and best practices in biologics manufacturing by hosting Workshops and Summits and by conducting projects related to the BioMAN Workstreams. BioMAN leverages the strengths of MIT faculty in the schools of Science, Engineering, and Management in all of these activities.


Provide a safe haven for collaborative, pre-competitive research among industry, academia, and government.

Provide a forum for companies to benchmark and identify best industry practices on the manufacture of existing and emerging therapies and be exposed to the novel technologies and capabilities of MIT most relevant to the biotherapeutics industry.

Increase awareness at MIT of unmet needs and opportunities in bioprocessing that map to faculty expertise.

Facilitate cross- and interdisciplinary research leveraging MIT’s world class expertise in engineering, science, economics, and business strategy to address challenges to the manufacturing and delivery of biologics.

Create impactful educational experiences to expand the reach of biomanufacturing education and to better connect theoretical concepts to real-world applications.


For more information or to join BioMAN, please contact:

Stacy L. Springs, PhD
Senior Director of Programs, CBI
Executive Director, Biomanufacturing Initiatives
Phone: 617-253-3084